Bar, J., Sharma, M. R., Kuboki, Y., Perets, R., Sommerhalder, D., Yamamoto, N., … Camidge, D. R. (2023). 163P Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors. In Annals of Oncology (Vol. 34, pp. S246–S247). Elsevier BV. https://doi.org/10.1016/j.annonc.2023.09.2887

Bar, J., M. R. Sharma, Y. Kuboki, R. Perets, D. Sommerhalder, N. Yamamoto, J. Powderly, et al. “163P Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors.” In Annals of Oncology, 34:S246–47. Elsevier BV, 2023. https://doi.org/10.1016/j.annonc.2023.09.2887.

Bar J, Sharma MR, Kuboki Y, Perets R, Sommerhalder D, Yamamoto N, et al. 163P Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors. In: Annals of Oncology. Elsevier BV; 2023. p. S246–7.

Bar, J., et al. “163P Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors.” Annals of Oncology, vol. 34, Elsevier BV, 2023, pp. S246–47. Crossref, doi:10.1016/j.annonc.2023.09.2887.

Bar J, Sharma MR, Kuboki Y, Perets R, Sommerhalder D, Yamamoto N, Powderly J, Strickler JH, Li M, Luo A, Morrison-Thiele G, Neagu Aristide MR, Vasilopoulos A, Camidge DR. 163P Genomic alterations in circulating tumor DNA (ctDNA) and response to ABBV-400 treatment in patients with advanced solid tumors. Annals of Oncology. Elsevier BV; 2023. p. S246–S247.